MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Prostate |
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read MorePosted by CLP Edit Staff | Nov 20, 2025 | Cerebrovascular |
The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.
Read MorePosted by CLP Edit Staff | Oct 14, 2025 | Hematology Instrumentation |
The DX-8 Series system combines CBC+DIFF, CRP, SAA, and HbA1c testing in a single platform with throughput up to 100 tests per hour.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Prenatal Testing |
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read MorePosted by CLP Edit Staff | Oct 7, 2025 | Diabetes & Metabolic Diseases |
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.
Read More